Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Bullboard Posts
Post by SanFrancisco99on Jun 30, 2015 11:29am
103 Views
Post# 23880982

Smear Campaign?

Smear Campaign?GV:  Leveling an unfounded campaign against a company by spreading a rumour that they are insolvent is a very serious thing.  

Of course, Zenith is not insolvent.  So you can't do that directly.  Instead, you put a little "IF" clause in your statement.  IF you redefine insolvency in a way that it has never been defined before, you can then label them "insolvent" or "bankrupt" under your new definition of those terms.

Interestinly, you very cleverly REMOVE THEIR KEY ASSET FROM YOUR NEW DEFINTION:  THEIR PATENTS and IP.  That's so very clever of you.

You can't do that in fairness.  The result is a smear.

If your intentions are good, you'd correct yourself and apologize for being so misleading.  But you won't do that.

Now you want to move on - because you've been called out.  You can't answer my questions directly because you know I am correct.

OK... let's move on.  But with the knowledge that you are an operator either driven by ego or other motives.

The record is clear:  Zenith has met all of its obligations and continues to do so.  There is no evidence anywhere that they are not able to do that.  If you can produce such evidence, then I will apologize to you.  But you can't, can you???





Bullboard Posts